UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$591M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$493M |
| 3 |
Broadcom
AVGO
|
+$481M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$460M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$503M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$368M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$279M |
| 5 |
Fidelity National Information Services
FIS
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Financials | 7.1% |
| 3 | Healthcare | 6% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Industrials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5701
Regional Management Corp
RM
$303M
| $229K | ﹤0.01% |
9,123
+4,595
| +101% | +$111K |
|
5702
Pulse Biosciences
PLSE
$3.02B
| $228K | ﹤0.01% |
18,661
+9,632
| +107% | +$66.7K |
|
5703
TXO Partners LP
TXO
$760M
| $228K | ﹤0.01% |
12,557
+10,052
| +401% | +$190K |
|
5704
Enlight Renewable Energy
ENLT
$11.9B
| $227K | ﹤0.01% |
11,858
-3,911
| -25% | -$61.2K |
|
|
JMIA
5705
Jumia Technologies
JMIA
$767M
| $227K | ﹤0.01% |
64,274
+5,112
| +9% | +$15.4K |
|
5706
Nkarta
NKTX
$172M
| $226K | ﹤0.01% |
34,284
+19,978
| +140% | +$51.8K |
|
|
FTHY
5707
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$498M
| $226K | ﹤0.01% |
16,218
-9,190
| -36% | -$123K |
|
5708
PUT
iShares S&P 500 Growth ETF
IVW
$77.6B
| $225K | ﹤0.01% |
3,000
| – | – |
|
5709
Annexon
ANNX
$886M
| $225K | ﹤0.01% |
49,586
+24,937
| +101% | +$61.7K |
|
|
ACV
5710
Virtus Diversified Income & Convertible Fund
ACV
$282M
| $225K | ﹤0.01% |
10,729
-3,445
| -24% | -$65.5K |
|
5711
AC Immune
ACIU
$240M
| $225K | ﹤0.01% |
45,000
+2,026
| +5% | +$6.51K |
|
|
PSTX
5712
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $225K | ﹤0.01% |
66,952
+31,144
| +87% | +$80.2K |
|
|
HFRO
5713
Highland Opportunities and Income Fund
HFRO
$407M
| $225K | ﹤0.01% |
29,231
-339
| -1% | -$2.68K |
|
5714
Atlanticus Holdings
ATLC
$1.52B
| $224K | ﹤0.01% |
5,794
+2,509
| +76% | +$79K |
|
5715
Fennec Pharmaceuticals
FENC
$402M
| $224K | ﹤0.01% |
19,969
+9,979
| +100% | +$82.7K |
|
|
ZYXI
5716
DELISTED
Zynex
ZYXI
| $224K | ﹤0.01% |
20,558
-1,847
| -8% | -$16.4K |
|
5717
Quantum-Si Incorporated
QSI
$177M
| $223K | ﹤0.01% |
111,189
+50,964
| +85% | +$77.7K |
|
|
ASXC
5718
DELISTED
Asensus Surgical, Inc.
ASXC
| $222K | ﹤0.01% |
696,957
+27,626
| +4% | +$7.12K |
|
|
TDF
5719
Templeton Dragon Fund
TDF
$280M
| $222K | ﹤0.01% |
27,198
-10,663
| -28% | -$88.8K |
|
|
AXIA
5720
AXIA Energia
AXIA
| $222K | ﹤0.01% |
32,454
-62,037
| -66% | -$381K |
|
5721
Eltek
ELTK
$59.5M
| $220K | ﹤0.01% |
15,798
+832
| +6% | +$9.74K |
|
5722
iShares MSCI China Small-Cap ETF
ECNS
$66.4M
| $220K | ﹤0.01% |
8,584
+4,101
| +91% | +$109K |
|
5723
ProShares Ultra S&P500
SSO
$8.36B
| $220K | ﹤0.01% |
6,764
+6,484
| +2,316% | +$186K |
|
|
IBHE
5724
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
| $220K | ﹤0.01% |
9,510
| – | – |
|
5725
Rigel Pharmaceuticals
RIGL
$750M
| $219K | ﹤0.01% |
15,136
+7,319
| +94% | +$74.8K |
|
Similar funds
UBS Group's Q4 2023 Portfolio in Review
As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.
- UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
- UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
- UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
- UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
- UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
- UBS Group opened 1,223 new positions and closed 1,397 in Q4 2023.
- UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.